The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...

A YOUNG woman who thought nothing of her urinary tract infection was later told she in fact had cancer and thought she might ...

Urinary tract infections are common, especially, though not exclusively, in women, and the risk generally increases with age.

This is the first approved indication for Orlynvah and the first FDA-approved product for Iterum. "We are so pleased to have achieved this historic milestone and would like to thank all the patients, ...

Salve Regina chemistry professor Dr. Susan Meschwitz’s study will explore treatment options for this common infection.

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...

Dr Catherine Hood explains that cotton is always the best choice thanks to its breathability.

The clinical-stage pharmaceutical company said Friday that the Food and Drug Administration has approved its new drug application for Orlynvah as a treatment for uncomplicated urinary tract infections ...

It affects millions of Americans, most of them women and people assigned female ... Temporary incontinence could be caused by a urinary tract infection, pregnancy, constipation, and certain ...

Latest News and Articles on Women\'s Health. Read stories and expert opinion articles on Women\'s Health at thehealthsite.com ...

Canada’s newest provider of on-demand menopause care is sponsoring the event on October 26 in Toronto.

On Wednesday, the FDA accepted GSK plc’s (NYSE:GSK) marketing application seeking approval for gepotidacin, an ...